Are you 18 years or older? Are you being treated with lifestyle changes or treated with one or more oral diabetes medications?
At a glance:
The University of Alabama at Birmingham, Department of Nutrition Sciences, in collaboration with Novo Nordisk, is conducting a 78 week research study to look into how well semaglutide once weekly medicine works in participants with obesity and type 2 diabetes.
About the Study
Qualified participants will receive study drug free of charge and may be compensated for time and travel.
PI: Dr. Tim Garvey
Contact
Tracie Thomas
205-996-4015